Lawsuit says Novo, OptumRx 'mutually benefited' from rebate scheme, while consumers paid the price
admin 26th May 2017 Uncategorised 0Novo Nordisk is the target, along with pharmacy benefit manager OptumRX, of a new proposed class action lawsuit claiming a conspiracy to raise the price of diabetes medicines so that the drugmaker could pay rebates to the pharmacy benefit manager.
More: Lawsuit says Novo, OptumRx 'mutually benefited' from rebate scheme, while consumers paid the price
Source: fierce